Adtrinib 200mg Tablet 30s

Introduction to Adtrinib 200mg Tablet 30s

Adtrinib 200mg Tablet 30s is a medication primarily used to treat certain types of cancer. This tablet form of Adtrinib is designed to help slow down the growth of cancer cells and reduce tumors, particularly in cases where other treatments have not been effective or are unsuitable.

Composition of Adtrinib 200mg Tablet 30s

Adtrinib 200mg Tablet 30s contains the active ingredient Sorafenib, which functions by inhibiting specific proteins known as kinases. These proteins are involved in the growth and division of cancer cells, and by blocking them, Sorafenib helps to control the progression of the disease.

Uses of Adtrinib 200mg Tablet 30s

• Treatment of liver cancer
• Treatment of kidney cancer
• Treatment of thyroid cancer

Side effects of Adtrinib 200mg Tablet 30s

• Common side effects: Diarrhea, fatigue, skin reactions such as rash or redness
• Serious side effects: Heart problems, high blood pressure, bleeding

Precautions of Adtrinib 200mg Tablet 30s

Adtrinib 200mg Tablet 30s may cause serious side effects, including heart issues, high blood pressure, and bleeding, which require careful monitoring. It is contraindicated in individuals with severe liver impairment and those with known allergies to the medication.

How to Take Adtrinib 200mg Tablet 30s

The usual starting dose for adults is 400 mg twice daily, which means taking two 200 mg tablets in the morning and two in the evening. Adtrinib 200mg Tablet 30s should be taken as part of a comprehensive cancer treatment plan, and it is important to follow your doctor's instructions regarding its use.

Conclusion of Adtrinib 200mg Tablet 30s

Adtrinib 200mg Tablet 30s, containing Sorafenib, is a therapeutic agent used in the treatment of liver, kidney, and thyroid cancers. It is manufactured to provide an effective option when other treatments are not suitable. This medication is crucial for managing cancer growth and requires careful adherence to prescribed guidelines to ensure safety and efficacy.